Clinical Trials for Diabetes Type 2

SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF

NCT ID: NCT06442280

This clinical trial is looking at a new treatment approach for patients who are hospitalized due to acute heart failure, a condition where the heart doesn't pump blood as well as it should. The stu...

Exploration of Health Literacy in Diabetes in Reunion Island and France

NCT ID: NCT06437782

This clinical trial is looking to understand how well diabetic patients in Reunion Island and France can access and understand health information related to their condition. The goal is to learn mo...

Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes

NCT ID: NCT06439758

This clinical trial is studying how different treatments for Type 2 diabetes (T2DM) affect bone health in newly diagnosed Saudi adults. The researchers want to find out if taking the diabetes medic...

Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

NCT ID: NCT06319300

This clinical trial is studying how well an artificial intelligence (AI) system can help manage insulin doses for people with type 2 diabetes who are in the hospital. The trial involves 140 patient...

The Effect of Semaglutide on Cardiovascular Markers and Liver Function

NCT ID: NCT06301191

This clinical trial is studying how a medication called semaglutide affects heart and liver health in patients with type 2 diabetes and a condition known as non-alcoholic fatty liver disease (NAFLD...

Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes

NCT ID: NCT06129526

This clinical trial aims to study the effects of a supplement called Eicosapentaenoic acid (EPA) in patients with type 2 diabetes who are at high risk for heart problems. Specifically, the research...

Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety

NCT ID: NCT05915949

**Summary of the Clinical Trial on Diabetes Treatment** This clinical trial is studying the effectiveness and safety of three different treatments for Type 2 diabetes: Dapagliflozin, Lobeglitazone...

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study

NCT ID: NCT05530356